Glow Capital Partners has acquired a majority stake in Delta Laboratories, a prominent contract manufacturer of personal care products, to enhance its presence in the growing Australian cosmetics market.
Information on the Target
Delta Laboratories, established over 40 years ago by Gary Leach, has emerged as a key player in the contract manufacturing sector for personal care and cosmetics. Located in Somersby, New South Wales, the company is renowned for its specializations in producing cosmetics, sunscreen, and therapeutic skincare products. Delta Laboratories boasts Therapeutic Goods Administration (TGA) registration, which underpins its commitment to high-quality product manufacturing, ensuring compliance with Australian standards and facilitating success for numerous beauty brands both locally and globally.
Over the decades, Delta Laboratories has built a strong reputation for quality and reliability, making it a trusted partner for many esteemed Australian and international beauty brands. The company's extensive experience in the industry positions it well to capitalize on the growing demand for personalized and innovative skincare products.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Australia
The personal care and cosmetics industry in Australia has experienced significant growth in recent years, driven by increasing consumer demand for high-quality, effective beauty products. This trend is further amplified by r
Similar Deals
BCI, Paine Schwartz Partners and Driscoll’s → Costa Group
2024
Didi Lo and consortium → Wallaby Foods
2023
Glow Capital Partners
invested in
Delta Laboratories
in 2025
in a Buyout deal